Oaktree Specialty Lending Corporation (“OCSL”)and Oaktree Strategic Income II, Inc. (“OSI II”) entered into an agreement to merge together with OCSL as the surviving company, subject to stockholder approval and customary closing conditions. The...
Read Story
September 20, 2022, 07:35 AM
|
Marinus Pharmaceuticals received $30 million in funding under the existing Oaktree Capital Management credit agreement. This additional funding became available as a result of the U.S. Food and Drug Administration’s (FDA) recent approval of the...
Read Story
April 01, 2022, 07:00 AM
|
Oaktree Specialty Lending Corporation announced the closing of the previously announced merger with Oaktree Strategic Income Corporation (“OCSI”), with OCSL as the surviving company. Based on December 31, 2020 financial information, the combined...
Read Story
March 22, 2021, 07:58 AM
|
Oaktree Specialty Lending Corporation entered into an amendment to its amended and restated senior secured credit facility among the Company, the lenders party thereto, ING Capital LLC, as administrative agent, ING Capital LLC, JPMorgan Chase Bank, N...
Read Story
December 15, 2020, 08:00 AM
|
Oaktree Specialty Lending Corporation announced that it has upsized and extended its senior secured revolving credit facility. Total commitments to the amended facility increased from $600 million to $680 million and the final maturity was extended...
Read Story
February 27, 2019, 09:00 AM
|
Oaktree Specialty Lending Corporation, a specialty finance company, today announced that it has entered into a new secured revolving credit facility. The Facility’s total capacity is $600 million, the revolving period expires in November 2020, and...
Read Story
December 01, 2017, 07:38 AM
|
Oaktree Capital Group, LLC announced that Oaktree Capital Management, L.P. has closed its asset purchase agreement pursuant to which Oaktree has become the new investment adviser to two business development companies (BDCs): Oaktree Specialty...
Read Story
October 19, 2017, 07:09 AM
|